Skip to main content

PharmacoEconomics

Ausgabe 8/2023

Inhalt (9 Artikel)

Leading Article

How Much Better is Faster? Value Adjustments for Health-Improvement Sequences

F. Reed Johnson, Juan Marcos Gonzalez, John J. Sheehan, Shelby D. Reed

Open Access Review Article

Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Willem Witlox, Sabine Grimm, Jeremy Howick, Nigel Armstrong, Charlotte Ahmadu, Kevin McDermott, Thomas Otten, Caro Noake, Robert Wolff, Manuela Joore

Systematic Review

Cost-Effectiveness of Thrombopoietin Mimetics in Patients with Thrombocytopenia: A Systematic Review

Hans Van Remoortel, Hans Scheers, Bert Avau, Jørgen Georgsen, Susan Nahirniak, Nadine Shehata, Simon J. Stanworth, Emmy De Buck, Veerle Compernolle, Philippe Vandekerckhove

Open Access Systematic Review

Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review

Charles Okafor, Joshua Byrnes, Simon Stewart, Paul Scuffham, Clifford Afoakwah

Open Access Original Research Article

Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer

Marianne Luyendijk, Agnes Jager, Sanne M. Buijs, Sabine Siesling, Carin A. Uyl-de Groot, Hedwig M. Blommestein

Open Access Original Research Article

Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)

Maria Jesus Rodríguez-Nieto, Esteban Cano-Jiménez, Ana D. Romero Ortiz, Ana Villar, Marta Morros, Alba Ramon, Silvia Armengol

Original Research Article

Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers

Aurelie Meunier, Louise Longworth, Manuel Gomes, Sreeram Ramagopalan, Louis P. Garrison, Sanjay Popat